ORPHEUS

OFFICIAL TITLE: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INCMGA00012 IN ADVANCED PENILE SQUAMOUS CELL CARCINOMA – ORPHEUS

PROJECT DETAILS

ORPHEUS IS AN INTERNATIONAL, MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II CLINICAL TRIAL IN MEN WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PENILE SQUAMOUS CELL CARCINOMA (PSCC).
THE PRIMARY GOAL IS TO ASSESS THE EFFICACY –AS DETERMINED BY THE OBJECTIVE RESPONSE RATE (ORR)– OF INCMGA00012 IN THE STUDY POPULATION.
IN ADDITION, THIS STUDY WILL ALSO EVALUATE THE SAFETY AND TOLERABILITY OF INCMGA00012 IN THESE PATIENTS.

ORPHEUS AT CLINICALTRIALS.GOV

TUMOR TYPE

PHASE

PENILE

II

18

12

Spain, Italy

N

SITES

COUNTRY

STATUS

Recruiting

ORPHEUS SITES

SPAIN

ICO L'Hospitalet. Catalan Institute of Oncology

SPAIN

Hospital Insular de Gran Canaria

SPAIN

Hospital Virgen de la Arrixaca

SPAIN

Hospital Virgen del Rocío

SPAIN

Hospital Miguel Servet

SPAIN

Instituto Valenciano de Oncología

SPAIN

Hospital de la Santa Creu i Sant Pau

SPAIN

Hospital Universitario Doce de Octubre

SPAIN

Hospital Clínico San Carlos

SPAIN

Hospital Universitari Son Espases

ITALY

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.

ITALY

AUSL Reggio Emilia